AutoLumo - Autobio Philippines

12/03/2026

Rheumatoid arthritis (RA) is an autoimmune disease marked by synovitis, pannus formation, and progressive cartilage and bone destruction. Detection of key autoantibodies—particularly Rheumatoid Factor (RF) and Anti-CCP—remains fundamental in RA classification and laboratory diagnosis.

📊 Explore a quick overview of RA below:

06/03/2026

Detect Antiphospholipid Syndrome (APS) biomarkers in just 40 minutes using Autobio’s CLIA-ready platform—delivering accurate, quantitative results aligned with 2023 ACR/EULAR criteria ✅💯

⚙️ Streamlines lab workflows
🔬 Reduces operator dependency
⚡️ Accelerates reporting for faster clinical decisions

05/03/2026

⚠️ Colorectal cancer is more common than you think.

🔴 Prevention begins with awareness, and early screening makes all the difference.

Reference: https://psgastro.org/colorectal-cancer-crc/

02/03/2026

Stronger together in the fight against colorectal cancer 💙

Colorectal cancer develops slowly over many years, often beginning as a polyp or abnormal growth in the inner lining of the colon or re**um. Because it progresses gradually, early screening plays a critical role in prevention and early detection.

Globally, colorectal cancer remains one of the leading causes of cancer-related deaths, affecting predominantly individuals over 50 years old.

The good news? When detected early, colorectal cancer is highly preventable and treatable. ✅

This Colorectal Cancer Awareness Month, let’s turn awareness into action.
Encourage screening. Start conversations. Prioritize prevention.

27/02/2026

Colorectal Cancer (CRC) remains one of the leading causes of cancer mortality worldwide.

Accurate biomarker assessment plays a crucial role in early detection, prognosis, and monitoring recurrence.

🔎 Read more below about the clinical significance of CEA, CA19-9, CA242, CA50, and CA125.

25/02/2026

Respiratory Tract Infections aren’t just “simple colds.” 🦠

Understand their clinical significance and why early detection matters. Read more below 👇

25/02/2026

20/02/2026

📸 Highlights from the 2nd Annual Convention of the Philippine Society of Maritime Health Physicians – February 19, 2026

We were truly honored to participate in this distinguished gathering, where we had the opportunity to share insights and contribute to the advancement of healthcare for seafarers and maritime professionals.

During the event, we also delivered a presentation on why the AutoLumo S900 is the faster and smarter choice, highlighting how its technology enables more efficient and reliable laboratory performance.

We extend our sincere appreciation to everyone who visited our booth and engaged with us. Your support inspires us to continue promoting the health, safety, and well-being of those who serve at sea. ⚓🩺

18/02/2026

Blue Cross is set to make waves in maritime medicine! 🌊⚓

We’re excited to announce our participation in the 2nd Annual Convention of the Philippine Society of Maritime Health Physicians, entitled “Navigating Health, Anchoring Wellness: Advancing Maritime Medicine for Physicians and Specialists”

📅 February 19, 2026
📍 Seda Hotel Manila Bay, Parañaque City.

Join us as we explore innovative solutions and advancements in health care for seafarers and maritime professionals!

12/02/2026

🚀 Here’s a glimpse of the Ci-120x: Big Performance in a Compact Design

The Ci-120x is a fully automated benchtop coagulation analyzer built for small to medium-sized labs, but don’t let its size fool you — it rivals high-end devices in functionality and performance.

👀 Check out the image to see its features!

10/02/2026

Big news! 🎉

We are pleased to announce that Autobio’s hs-cTnT assay has received an IFCC C-CB Recommendation, affirming its quality, reliability, and compliance with international standards.

A significant step forward in reliable and timely cardiac diagnostics. 💙

🔗 https://ifcc.org/ifcc-education-division/emd-committees/committee-on-clinical-applications-of-cardiac-bio-markers-c-cb/biomarkers-reference-tables/